Lanean...
547. Results of Patient-Reported Outcome Data From the Phase III BRIGHTE Study of Fostemsavir
BACKGROUND: The Phase 3 BRIGHTE study evaluated fostemsavir in heavily treatment experienced HIV-1 patients failing their current antiretroviral (ARV) regimen and unable to construct a viable regimen from remaining available agents. Week 24 efficacy and safety have been previously reported—fostemsav...
Gorde:
| Argitaratua izan da: | Open Forum Infect Dis |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6255559/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.555 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|